Absolutely thrilled to witness the groundbreaking transformation happening in the life sciences ecosystem! 🚀 Today, 2 Bridge is challenging the status quo by adopting a revolutionary tiger team approach, redefining the future of scaling up in the industry.
Kynexis, a shining example partnered with 2 Bridge from day one, achieved major milestones in less than 12 months. Kees Been, CEO of Kynexis, highlights the impact of collaborative expertise in their impressive journey to a €57 million Series A round. 🌟💰
AbolerIS Pharma, another success story, secured a €27.3 million Series A financing, showcasing the effectiveness of the tiger team approach in elevating success through collaboration. 🤝💼
These narratives underscore the transformative power of tiger teams for early-stage life sciences companies—overcoming scaling-up challenges and pioneering innovative solutions for unmet medical needs. 👩🔬
Read more in our article on how the tiger team approach is set to redefine the life sciences startup landscape, driving innovation, fostering partnerships, and propelling scientific breakthroughs. 👇️
https://loom.ly/pyt-C4I
#lifesciences #innovation #tigerteamapproach #startuprevolution